Brief: Grand Pharmaceutical Says Neffy Obtains Drug Registration Certificate From China's NMPA
29/12/2025 10:22
Dec 29 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK: NEFFY® OBTAINS DRUG REGISTRATION CERTIFICATE FROM CHINA'S NMPA Further company coverage: 0512.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement